Lomefloxacin maganin rigakafi ne na fluoroquinolone da ake amfani da shi don magance cututtukan ƙwayoyin cuta daban-daban. Yana aiki ta hanyar hana gyrase DNA na kwayan cuta, wani enzyme mai mahimmanci don kwafin DNA na kwayan cuta. An ba da wannan magani don yanayi kamar cututtuka na urinary fili, cututtuka na numfashi, da wasu cututtukan fata. Duk da yake yana da tasiri akan nau'ikan ƙwayoyin cuta da yawa, lomefloxacin ba a saba amfani dashi azaman jiyya ta farko ba saboda yuwuwar illolin da ke tattare da samuwar sabbin hanyoyin aminci.
Lomefloxacin, kamar sauran maganin rigakafi na fluoroquinolone, na iya haifar da kewayon illolin da marasa lafiya da ma'aikatan kiwon lafiya ya kamata su sani. Abubuwan da aka saba amfani da su sun haɗa da rikicewar ciki, kamar tashin zuciya, gudawa, da ciwon ciki. Wadannan alamomin yawanci suna da laushi kuma suna iya warwarewa da kansu yayin da jiki ya daidaita da magani.
Duk da haka, wasu marasa lafiya na iya samun sakamako mai tsanani wanda ke buƙatar kulawar likita. Daya daga cikin mahimman abubuwan damuwa lomefloxacin shine yuwuwar sa na haifar da phototoxicity. Wannan yanayin yana sa fata ta fi dacewa da hasken rana kuma zai iya haifar da mummunar kunar rana, kumburi, ko rashes lokacin da aka fallasa ga hasken UV. An shawarci marasa lafiya da ke shan lomefloxacin da su guji yawan faɗuwar rana kuma su yi amfani da matakan kariya da suka dace.
Tasirin tsarin juyayi na tsakiya wani yanki ne na damuwa tare da amfani da lomefloxacin. Wasu marasa lafiya na iya samun ciwon kai, dizziness, ko rashin barci. A lokuta da ba kasafai ba, an ba da rahoton ƙarin alamun cututtukan jijiya kamar su tashin hankali ko ruɗi. Wadannan sakamako masu illa sun fi faruwa a cikin tsofaffi marasa lafiya ko wadanda ke da tarihin cututtuka na tsakiya na tsakiya.
Har ila yau, an haɗu da illa na ƙwayoyin tsoka tare da lomefloxacin da sauran fluoroquinolones. Marasa lafiya na iya samun ciwon haɗin gwiwa, raunin tsoka, ko tendinitis. A wasu lokuta, waɗannan illolin na iya haifar da tsagewar jijiyoyi, musamman a cikin jijiyar Achilles. Wannan haɗari ya fi girma a cikin tsofaffi, waɗanda ke shan corticosteroids, da marasa lafiya da tarihin cututtuka na tendon.
Yana da mahimmanci a lura cewa yayin da waɗannan illolin za su iya faruwa, duk marasa lafiya ba su da kwarewa. Masu ba da lafiya a hankali suna auna fa'idodin lomefloxacin akan yuwuwar haɗarin sa lokacin rubuta wannan magani. Ya kamata a ƙarfafa majiyyata da su ba da rahoton duk wani alamun da ba a saba gani ba ko illa ga likitansu da sauri.
Lomefloxacin na cikin nau'in maganin rigakafi na fluoroquinolone, wanda ya haɗa da wasu sanannun magunguna irin su ciprofloxacin, levofloxacin, da moxifloxacin. Lokacin kwatanta lomefloxacin zuwa takwarorinsa, abubuwa da yawa sun shigo cikin wasa, gami da inganci, bakan ayyuka, da bayanin martaba.
Dangane da inganci, lomefloxacin ya nuna yana da tasiri a kan nau'ikan nau'ikan gram-korau da wasu kwayoyin cutar gram-positive. Yana da amfani musamman wajen magance cututtukan da ke damun yoyon fitsari saboda yawan tattarawar da yake da shi a cikin tsarin fitsari. Koyaya, idan aka kwatanta da sabbin ƙwayoyin fluoroquinolones kamar levofloxacin ko moxifloxacin, lomefloxacin na iya samun ɗan ƙaramin bakan na ayyuka akan wasu ƙwayoyin cuta.
Ɗayan da ke bambanta yanayin lomefloxacin shine tsawon rabin rayuwarsa idan aka kwatanta da wasu nau'in fluoroquinolones. Wannan yana ba da damar yin allurai sau ɗaya a rana, wanda zai iya haɓaka yarda da haƙuri. Duk da haka, wannan tsawaita rabin rayuwar kuma yana ba da gudummawa ga haɓakar haɗarin phototoxicity, wani sakamako mara kyau wanda ba a saba gani tare da sauran fluoroquinolones.
Idan ya zo ga aminci, lomefloxacin yana raba yawancin illa masu illa masu alaƙa da fluoroquinolones. Duk da haka, babban haɗarinsa na phototoxicity ya bambanta shi da wasu takwarorinsa. Wannan ƙarin haɗarin ya haifar da ƙarin taƙaita amfani da lomefloxacin a wasu ƙasashe, tare da sabbin fluoroquinolones galibi ana fifita su saboda ingantattun bayanan martaba.
Dangane da juriya na ƙwayoyin cuta, duk fluoroquinolones suna fuskantar ƙalubale yayin da yawan amfani da su ya haifar da haɓaka juriya na ƙwayoyin cuta. Lomefloxacin bai keɓanta da wannan yanayin ba, kuma tasirin sa akan wasu ƙwayoyin cuta na iya raguwa da lokaci.
Yana da daraja a lura cewa zabi tsakanin lomefloxacin da sauran maganin rigakafi sukan dogara da dalilai kamar takamaiman kamuwa da cuta da ake bi da su, yanayin juriya na gida, halayen haƙuri, da yuwuwar hulɗar miyagun ƙwayoyi. Dole ne ma'aikatan kiwon lafiya suyi la'akari da waɗannan abubuwan a hankali lokacin zabar maganin rigakafi mafi dacewa ga kowane majiyyaci.
Lokacin rubuta lomefloxacin, masu ba da kiwon lafiya dole ne su san wasu mahimman ka'idodi da contraindications don tabbatar da amincin haƙuri da ingantaccen sakamakon jiyya.
Ofaya daga cikin mahimman abubuwan hana amfani da lomefloxacin shine sanannen hypersensitivity ga miyagun ƙwayoyi ko wasu fluoroquinolones. Marasa lafiyan da suka fuskanci rashin lafiyar kowane maganin rigakafi na fluoroquinolone bai kamata a sanya su lomefloxacin ba saboda haɗarin giciye-reactivity.
Ciki da shayarwa suma suna da matukar muhimmanci. Ba a ba da shawarar Lomefloxacin gabaɗaya yayin daukar ciki saboda yuwuwar haɗari ga tayin mai tasowa. Nazarin dabba ya nuna illa ga ci gaban tayin, kuma yayin da bayanan ɗan adam ke iyakance, haɗarin haɗari ya fi fa'ida a mafi yawan lokuta. Hakazalika, ana iya fitar da lomefloxacin a cikin madarar nono, wanda zai iya shafar jarirai masu shayarwa, don haka amfani da shi yayin shayarwa yawanci yakan hana.
Marasa lafiya da ke da tarihin cututtukan jijiyoyi ko waɗanda ke cikin haɗarin haɗarin tendinitis da tsagewar jijiya yakamata su yi amfani da su. lomefloxacin tare da taka tsantsan. Wannan ya haɗa da tsofaffi marasa lafiya, waɗanda ke amfani da corticosteroids, da kuma mutanen da ke da tarihin matsalolin tendons. Ya kamata a kula da waɗannan marasa lafiya a hankali kuma a shawarce su su ba da rahoton duk wani alamun ciwon jijiya ko kumburi nan da nan.
Lomefloxacin kuma yana iya yin hulɗa tare da magunguna da yawa, yana buƙatar yin la'akari da kyau game da tsarin magungunan majiyyaci na yanzu. Alal misali, yana iya ƙara tasirin magungunan maganin jini na baka kamar warfarin, wanda zai iya haifar da haɗarin zubar jini. Yin amfani da juna tare da magungunan da ke tsawaita tazarar QT ya kamata a guji saboda haɗarin arrhythmias na zuciya.
Marasa lafiya da ke da tarihin kamawa ko wasu rikice-rikice na tsarin juyayi na tsakiya yakamata suyi amfani da lomefloxacin a hankali, saboda yana iya rage matakin kamawa. Hakazalika, waɗanda ke da tarihin cutar tabin hankali na iya kasancewa cikin haɗarin haɗarin cututtukan neuropsychiatric.
Raunin koda shine wani muhimmin abin la'akari, kamar yadda lomefloxacin ke fitar da kodan da farko. Daidaita sashi na iya zama dole ga marasa lafiya tare da rage aikin koda don hana tarin ƙwayoyi da yuwuwar guba.
Idan aka yi la'akari da yuwuwar phototoxic na lomefloxacin, ya kamata a shawarci marasa lafiya da su guji yawan faɗuwar rana kuma su yi amfani da matakan kariya daga rana da suka dace a duk lokacin jiyya da kuma na kwanaki da yawa bayan dainawa.
A ƙarshe, yana da mahimmanci a lura cewa amfani da fluoroquinolones, gami da lomefloxacin, yana da alaƙa da haɓakar haɗarin aortic aneurysm da rarrabawa, musamman a cikin tsofaffi. Marasa lafiya da ke da tarihin aneurysms ko waɗanda ke cikin haɗarin cutar aortic yakamata a tantance su a hankali kafin a ba su lomefloxacin.
Masu ba da lafiya dole ne su auna waɗannan matakan tsaro da yuwuwar contraindications akan fa'idodin lomefloxacin far ga kowane mai haƙuri. A yawancin lokuta, ana iya fifita madadin maganin rigakafi tare da ƙarin bayanan haɗarin haɗari, musamman ga marasa lafiya da ke da abubuwan haɗari masu yawa ko tarihin likita mai rikitarwa.
Idan kuma kuna sha'awar wannan samfurin kuma kuna son ƙarin cikakkun bayanai na samfur, ko kuna son sanin wasu samfuran masu alaƙa, da fatan za a iya tuntuɓar su. iceyqiang@aliyun.com.
References:
1. Ball, P. (2000). Zamanin Quinolone: tarihin halitta ko zaɓin yanayi? Jaridar Antimicrobial Chemotherapy, 46 (suppl_3), 17-24.
2. Blondeau, JM (2004). Fluoroquinolones: tsarin aiki, rarrabuwa, da haɓaka juriya. Binciken Kiwon Lafiyar Ido, 49(2), S73-S78.
3. Hooper, DC (2001). Hanyoyin aiki na antimicrobials: mayar da hankali kan fluoroquinolones. Cutar cututtuka na asibiti, 32 (Kari_1), S9-S15.
4. Owens Jr, RC, & Ambrose, PG (2005). Tsaro na rigakafi: mayar da hankali kan fluoroquinolones. Cutar cututtuka na asibiti, 41 (Kari_2), S144-S157.
5. Stahlmann, R., & Lode, H. (2010). La'akari da aminci na fluoroquinolones a cikin tsofaffi: sabuntawa. Magunguna & Tsufa, 27 (3), 193-209.
6. Tatro, DS (Ed.). (2003). Bayanan hulɗar miyagun ƙwayoyi. Gaskiya da Kwatance.
7. Van Bambeke, F., & Tulkens, PM (2009). Bayanan aminci na fluoroquinolone moxifloxacin na numfashi. Tsaron Magunguna, 32 (5), 359-378.
8. Zhanel, GG, Walkty, A., Vercaigne, L., Karlowsky, JA, Embil, J., Gin, AS, & Hoban, DJ (1999). Sabuwar fluoroquinolones: nazari mai mahimmanci. Jaridar Kanada na Cututtuka masu Yaduwa, 10 (3), 207-238.
9. Zhao, X., & Drlica, K. (2001). Ƙuntata zaɓin maye gurbi masu jure ƙwayoyin ƙwayoyin cuta: dabarun gaba ɗaya da aka samo daga binciken fluoroquinolone. Cutar cututtuka na asibiti, 33 (Kari_3), S147-S156.
10. Zvonar, R. (2006). Amfani da ƙwayoyin cuta a cikin sashin kulawa mai zurfi. Jaridar Amirka na Magungunan Kiwon Lafiya-Tsarin Magunguna, 63(10), 972-978.